Published in Acta Oncol on January 01, 1993
Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg (2005) 1.99
A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab (2008) 0.93
Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg (2004) 0.78
Clinical aspects of ECL-cell abnormalities. Yale J Biol Med (1999) 0.78
Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies. Virchows Arch (2006) 0.78
Proton pump inhibitors on pancreatic cancer risk and survival. Cancer Epidemiol (2017) 0.75
The stomach is a source of leptin. Nature (1998) 3.33
Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46
Sialic acid content and proteolytic activity in gastric juice in humans. An approach for appreciating mucus glycoprotein erosion. Dig Dis Sci (1988) 2.06
Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine (1993) 1.75
Utilization of paraffin-embedded material for electron microscopy. Study of an A2-cell type microadenoma of the endocrine pancreas. Lab Invest (1970) 1.70
False-positive somatostatin receptor scintigraphy due to an accessory spleen. J Nucl Med (1997) 1.67
Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun (1995) 1.60
Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet (1995) 1.59
[How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects]. Gastroenterol Clin Biol (1989) 1.51
Normal serum gastrin concentration in gastrinoma. Lancet (1995) 1.39
M or M-like protein gene polymorphisms in human group G streptococci. J Clin Microbiol (1995) 1.31
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28
Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg (1981) 1.27
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer (1993) 1.23
Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology (2001) 1.22
Are sphincter defects the cause of anal incontinence after vaginal delivery? Results of a prospective study. Dis Colon Rectum (2000) 1.22
Regression of inflammatory pseudotumor of the liver under conservative therapy. Dig Dis Sci (1995) 1.21
Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med (1997) 1.15
Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg (1979) 1.11
Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery (1995) 1.10
Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut (1992) 1.10
Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09
Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis (2001) 1.09
Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut (1997) 1.08
Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol (1988) 1.07
Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex. Clin Diagn Lab Immunol (1997) 1.06
Radioautographic and quantitative studies on parietal and peptic cell kinetics in the mouse. A selective effect of gastrin on parietal cell proliferation. Gastroenterology (1975) 1.06
Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology (1993) 1.04
Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr (1994) 1.03
Population kinetics of antral gastrin cells in the mouse. Gastroenterology (1976) 1.03
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut (1992) 1.03
Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring. Dig Dis Sci (1983) 1.02
Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study. Eur J Clin Nutr (1998) 1.01
Stimulating effect of bombesin on the growth of gastrointestinal tract and pancreas in suckling rats. Gastroenterology (1986) 1.00
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology (1999) 0.99
Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol (2001) 0.98
Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison. Gastroenterology (1996) 0.98
Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas (1993) 0.97
Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion (1979) 0.97
Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology (1989) 0.97
Identification of human transferrin-binding sites within meningococcal transferrin-binding protein B. J Bacteriol (1997) 0.96
Crohn's disease stable remission after human immunodeficiency virus infection. Dig Dis Sci (1998) 0.93
Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer (1987) 0.91
Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis (1999) 0.91
Developmental expression of transforming growth factor-alpha and epidermal growth factor receptor proteins in the human pancreas and digestive tract. Cell Tissue Res (1994) 0.91
Detection of gastrin mRNA in human antral mucosa and digestive endocrine tumors by in situ hybridization: a correlative study with immunocytochemistry and electron microscopy. J Histochem Cytochem (1992) 0.90
Peritoneal carcinomatosis in patients with digestive endocrine tumors. Cancer (1996) 0.89
Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem Biophys Res Commun (2001) 0.89
Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. Eur J Nucl Med (1994) 0.89
Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci (1993) 0.88
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process. Eur J Radiol (2001) 0.88
Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med (1999) 0.88
Effect of the histamine-1 antagonist astemizole alone or with omeprazole on rat gastric mucosa. Scand J Gastroenterol (1991) 0.88
[Increase of resting energy expenditure during flare-ups in Crohn disease]. Gastroenterol Clin Biol (1993) 0.88
Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig Dis Sci (1995) 0.87
Inhibitory effect of prolonged administration of long-acting somatostatin on gastrin-stimulated fundic epithelial cell growth in the rat. Digestion (1982) 0.87
Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. Br J Clin Pharmacol (1982) 0.87
Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis. Microsc Res Tech (2000) 0.86
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours. Digestion (1996) 0.86
Chronic administration of bombesin stimulates antral gastrin cell proliferation in the rat. Gastroenterology (1983) 0.85
Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man. Dig Dis Sci (1992) 0.85
Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol (1993) 0.84
Bombesin ingestion stimulates epithelial digestive cell proliferation in suckling rats. Am J Physiol (1989) 0.84
Management of Zollinger-Ellison syndrome. N Engl J Med (1980) 0.84
Effect of gastric juice on the absorption of iron. Surg Forum (1965) 0.84
[Influence of rectal preparation by enema on cell proliferation in the normal rectal mucosa in man]. Gastroenterol Clin Biol (1984) 0.84
[Malabsorption syndrome with mesenteric lymph node cavitation and splenic atrophy. Apropos of a new anatomo-clinical case]. Sem Hop (1974) 0.84
Comparison of polymorphonuclear cells from healthy donors and differentiated HL-60 cells as phagocytes in an opsonophagocytic assay using antigen-coated fluorescent beads. Clin Diagn Lab Immunol (2000) 0.84
Correlative immunocytochemical and electron microscopic studies: identification of (entero)glucagon- somatostatin- and pancreatic polypeptide-like-containing cells in the human colon. Histochemistry (1981) 0.84
Ranitidine and cimetidine in Zollinger-Ellison syndrome. Br J Clin Pharmacol (1980) 0.84
Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology (1993) 0.84
Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome. Digestion (1980) 0.83
Gynecomastia and histamine-2 antagonists. Lancet (1982) 0.83
Detection and localization by in situ molecular biology techniques and immunohistochemistry of hepatitis C virus in livers of chronically infected patients. J Histochem Cytochem (1998) 0.83
A case of scurvy presenting with cutaneous and articular signs. Clin Rheumatol (1993) 0.83
[Letter: Inhibitor of H 2 histamine receptors and the Zollinger-Ellison syndrome]. Nouv Presse Med (1974) 0.83
Serum gastrin levels in hypertrophic pyloric stenosis of infancy. Response to a gastrin secretion test. Arch Dis Child (1979) 0.83
Trophic effect of some regulatory peptides on gastric exocrine and endocrine cells of the rat. Scand J Gastroenterol Suppl (1984) 0.82
Quantitation of gastrin and somatostatin cell populations in the antral mucosa of the rat. Comparative distribution and evolution through different life stages. Cell Tissue Res (1979) 0.82
Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg (1998) 0.82
[Ranitidine effects on 24-hour intragastric pH in normal individuals. Interest of continuous monitoring for selection of an optimal therapeutic regimen (author's transl)]. Gastroenterol Clin Biol (1982) 0.82
Comparative effects of antrocolic transposition and antrectomy on fundic mucosa and acid secretion of the rat. Gastroenterology (1973) 0.81
Fine structural classification and comparative distribution of endocrine cells in normal human large intestine. Gastroenterology (1978) 0.81
[Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome]. Nouv Presse Med (1977) 0.81
Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest (1993) 0.81